NCT06315504View on ClinicalTrials.gov

Circulating Factors in Nephrotic Syndrome

Not yet recruitingOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2034

Study Completion Date

April 1, 2034

Conditions
Nephrotic SyndromeMembranous NephropathyMinimal Change DiseasePrimary Focal Segmental Glomerulosclerosis
Interventions
OTHER

Observation

Observation

All Listed Sponsors
lead

Iain Bressendorff

OTHER

NCT06315504 - Circulating Factors in Nephrotic Syndrome | Biotech Hunter | Biotech Hunter